Nanoparticles in cancer therapy and diagnosis
Top Cited Papers
- 25 August 2002
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 54 (5), 631-651
- https://doi.org/10.1016/s0169-409x(02)00044-3
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriersJournal of Controlled Release, 2001
- EWS Fli-1 Antisense Nanocapsules Inhibits Ewing Sarcoma-Related Tumor in MiceBiochemical and Biophysical Research Communications, 2000
- Antisense Oligonucleotide Delivery with Polyhexylcyanoacrylate Nanoparticles as CarriersMethods, 1999
- Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in cultureEuropean Journal Of Cancer, 1994
- Increased bone marrow toxicity of doxorubicin bound to nanoparticlesEuropean Journal Of Cancer, 1994
- Antibody-magnetite nanoparticles: In vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imagingBioconjugate Chemistry, 1993
- Diminished genotoxicity of mitomycin C and farmorubicin included in polybutylcyanoacrylate nanoparticlesMutation Research, 1992
- Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticlesCancer Chemotherapy and Pharmacology, 1990
- Increased eytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodaroneBiomaterials, 1989
- Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles: Increased efficiency against an experimental tumorEuropean Journal of Cancer (1965), 1980